New drug approval process [electronic resource] : the global challenge / edited by Richard A. Guarino.
Contributor(s): Guarino, Richard A
.
Material type: 
TextSeries: Drugs and the pharmaceutical sciences: v. 100.Publisher: New York : Marcel Dekker, c2000Edition: 3rd ed.General Notes: Available through the EBSCO e-book Collection, which can be found on the Davenport University Library database page.Bibliography: Includes bibliographical references and index.Description: 1 online resource (xxxiii, 471 p.) : ill.ISBN: 0585231362 (electronic bk.); 9780585231365 (electronic bk.).Subject(s): Drugs -- Testing -- Standards | Drugs -- Testing -- Government policy -- United States | New products -- Government policy -- United States | Clinical trials -- Standards -- United StatesGenre/Form: Electronic books DDC classification: 363.19/46/0973 Online resources: Access full-text materials at no charge: | Item type | Current library | Collection | Call number | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|
| E-book | Davenport Library e-book | E-book | 363.19/46/0973 (Browse shelf(Opens below)) | Not For Loan | mq341464 |
Browsing Davenport Library shelves, Shelving location: e-book , Collection: E-book Close shelf browser (Hides shelf browser)
Includes bibliographical references and index.
Available through the EBSCO e-book Collection, which can be found on the Davenport University Library database page.
Regulatory aspects of new drug development -- Clinical research development -- Good clinical practices -- The orphan drug and the Rx to OTC switch -- Effective methodology is expediting NDA approval.
Description based on print version record.
There are no comments on this title.